Health TrialsbyHealthPanel

Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis

ConditionIPF
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorIstanbul Medipol University Hospital

About this trial

It is to determine the effectiveness of different telerehabilitation exercise programs received to 2 groups randomly formed in idiopathic pulmonary fibrosis (IPF) patients. The cases meeting the inclusion criteria will be randomized and divided into two groups, the groups will be named as Telerehabilitation Exercise Group (TGr) and Video Group (VGr).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being between the ages of 18-75

Having a diagnosis of IPF disease diagnosed according to the following clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS)

Presence of dyspnea on exertion

Stable clinical state at the time of admission without infection or exacerbation in the previous 4 weeks

Disqualifiers

Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and needing high flow oxygen therapy (˃ 3-4 L \min).

A history of effort-related syncope or any comorbidity (such as severe orthopedic or neurological deficits or unstable heart disease) that precludes exercise training.

Participation in a pulmonary rehabilitation program within the past 12 months.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Telerehabilitation exercise program

    Other intervention

    TGr will be given online exercises, synchronized 2 days a week, and a home program for 1 day, accompanied by a physiotherapist, via videoconference on the group smartphone.

  • Videobased exercise program

    Other intervention

    After 1 session of online simultaneous exercise training in the company of a physiotherapist via videoconference on the smart phone, an exercise video including the exercises will be sent to them and the patients will be asked to do their exercises 3 days a week. The subjects will be asked to keep an exercise diary and the status of the diaries will be followed by calling them once a week.

Treatment groups

44 Participants
are divided into 2 treatment groups
Group A: Telerehabilitation Group (TG)Experimental treatment 1 intervention
Group B: Video Group (VGr)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

The exercise capacity

The exercise capacity will be assessed by the 6 minute walking test.The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines.

Time frame
Change from baseline 6 minute walking distance at 8 weeks

Secondary outcomes

1

Forced vital capacity (FVC)

Forced vital capacity will be assessed by the spirometer. Pulmonary function test will performe by using the Pony Fx spirometry device, and according to the American Thoracic Society (ATS) guidelines

Time frame
Change from baseline FVC at 8 weeks
2

Perception of dyspnea

Perception of dyspnea will be evaluated by Modified Medical Research Council Dyspnea scale. The mMRC Dyspnea Scale is best used to establish baseline functional impairment due to dyspnea attributable to respiratory disease; tracking the mMRC over time or with therapeutic interventions is of less certain clinical utility.The severity of dyspnea is rated on a scale of 0 to 4. "O" means no dyspnea perception, "4" means severe dyspnea perception.

Time frame
Change from baseline dyspnea perception at 8 weeks
3

Respiratory muscle strength

Respiratory muscle strength will be evaluated by the intraoral pressure measurement device.The mouth pressure measurement was performed with the Cosmed Pony Fx. Patient placed a rubber mouthpiece with flanges, on the device, sealed their lips firmly around the mouthpiece, exhaled/inhaled slowly and completely, and then tried to breath in as hard as possible. The patient was allowed to rest for about a minute and the maneuver was repeated five times. Verbal or visual feedback was provided after each maneuver. The aim is that the variability between measurements is less than 10 cm H2O. The maximum value was obtained.

Time frame
Change from baseline respiratory muscle strength at 8 weeks
4

Peripheral muscle strength

Peripheral muscle strength will be assessed by the hand held dynamometer

Time frame
Change from baseline peripheral muscle strength at 8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Istanbul Medipol University Hospital

Lead sponsor

Saglik Bilimleri Universitesi

Sponsor institution

Source ClinicalTrials.gov
Apply now